Graphing and reporting heterogeneous treatment effects through reference classes

by James A. Watson, Chris C. Holmes
Published 2020

Machine learning analysis plans for randomised controlled trials: Detecting treatment effect heterogeneity with strict control of type i error

by James A. Watson, Chris C. Holmes
Published 2020

Correction to: Graphing and reporting heterogeneous treatment effects through reference classes (Trials, (2020), 21, 1, (386), 10.1186/s13063-020-04306-1)

by James A. Watson, Chris C. Holmes
Published 2020

Questioning the Claimed Superiority of Malaria Parasite Ex Vivo Viability Reduction over Observed Parasite Clearance Rate?

by Nicholas J. White, James A. Watson
Published 2022

Tafenoquine for the prevention of Plasmodium vivax malaria relapse

by James A. Watson, Narimane Nekkab, Michael White
Published 2022

A semi-supervised learning framework for quantitative structure-activity regression modelling

by Oliver Watson, Isidro Cortes-Ciriano, James A. Watson
Published 2022

Falciparum malaria mortality in sub-Saharan Africa in the pretreatment era

by James A. Watson, Nicholas J. White, Arjen M. Dondorp
Published 2022

Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials

by Nicholas J. White, James A. Watson, J. Kevin Baird
Published 2022

Non-adherence in non-inferiority trials: Pitfalls and recommendations

by Yin Mo, Cherry Lim, James A. Watson, Nicholas J. White, Ben S. Cooper
Published 2020

A decision-theoretic approach to the evaluation of machine learning algorithms in computational drug discovery

by Oliver P. Watson, Isidro Cortes-Ciriano, Aimee R. Taylor, James A. Watson
Published 2020

Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria

by James A. Watson, Stije J. Leopold, Arjen M. Dondorp, Nicholas J. White
Published 2022

Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers

by Palang Chotsiri, Joel Tarning, Richard M. Hoglund, James A. Watson, Nicholas J. White
Published 2022

Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone marrow toxicities of the new trypanoside fexinidazole

by James A. Watson, Nathalie Strub-Wourgraft, Antoine Tarral, Isabela Ribeiro, Joel Tarning, Nicholas J. White
Published 2020

Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies

by James A. Watson, Stephen M. Kissler, Nicholas P.J. Day, Yonatan H. Grad, Nicholas J. White
Published 2022

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

by Nicholas J. White, James A. Watson, Richard M. Hoglund, Xin Hui S. Chan, Phaik Yeong Cheah, Joel Tarning
Published 2020

Stopping prereferral rectal artesunate-a grave error

by James A. Watson, Marian Warsame, Thomas J. Peto, Marie Onyamboko, Caterina Fanello, Arjen M. Dondorp, Nicholas White
Published 2022

The WHO guideline on drugs to prevent COVID-19: Small numbers- big conclusions

by William H.K. Schilling, James J. Callery, Arjun Chandna, Raph L. Hamers, James A. Watson, Nicholas J. White
Published 2022

Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria

by James A. Watson, Stije J. Leopold, Julie A. Simpson, Nicholas Pj Day, Arjen M. Dondorp, Nicholas J. White
Published 2020

Concentration-dependent mortality of chloroquine in overdose

by James A. Watson, Joel Tarning, Richard M. Hoglund, Frederic J. Baud, Bruno Megarbane, Jean Luc Clemessy, Nicholas J. White
Published 2020

A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices

by James A. Watson, Aimee R. Taylor, Elizabeth A. Ashley, Arjen Dondorp, Caroline O. Buckee, Nicholas J. White, Chris C. Holmes
Published 2020